GALPHIMIA GLAUCA WHOLE 1 [hp_X]/mL Liquid, 2000 mL — NDC 64743-274-01 (Billing 64743-0274-01)
This is a package of 2,000 mL of GALPHIMIA GLAUCA WHOLE 1 [hp_X]/mL Liquid from Herbamed AG, marketed since Aug 2020 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 64743-274-01 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 64743 labeler · 274 product · 01 package
- Package marketed since
- Aug 7, 2020
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 6474327401 3
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
This is a liquid preparation containing galphimia glauca whole plant extract at a concentration of 1 part per milliliter, marked for further processing rather than direct consumer use. Galphimia glauca, also known as golden thryallis, is a plant commonly used in herbal and homeopathic products. The extract is typically prepared for incorporation into other formulations or for dilution in manufacturing. As a drug for further processing, this product is not intended for direct patient use in its current form.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 6, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 64743-0274-01 You're viewing this Main listing | 2000 mL in 1 CANISTER | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Galphimia Glauca Whole 1 [hp_X]/mLthis 64743-0274-01 | Herbamed | 2000 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Herbamed AG labeler code 64743
- AETHUSA CYNAPIUM 1 [hp_X]/L Liquid NDC 64743-268-01
- ARTEMISIA ABROTANUM WHOLE 1 [hp_X]/L Liquid NDC 64743-269-01
- CARAPICHEA IPECACUANHA WHOLE 1 [hp_X]/L Liquid NDC 64743-270-01
- USTILAGO MAYDIS 1 [hp_X]/mL Liquid NDC 64743-271-01
- BALSAM PERU 1 [hp_X]/mL Liquid NDC 64743-272-01
- LILIUM LANCIFOLIUM WHOLE 1 [hp_X]/mL Liquid NDC 64743-273-01
- ECHINACEA ANGUSTIFOLIA 1 [hp_X]/mL Liquid NDC 64743-277-01
- ARTEMISIA VULGARIS ROOT 1 [hp_X]/mL Liquid NDC 64743-278-01
- ACIDUM SILICIUM 6 [hp_X]/mL Liquid NDC 64743-281-01
- Delphinium staphisagria 1 [hp_X]/mL Liquid NDC 64743-282-01
- CALENDULA OFFICINALIS 1 [hp_X]/mL Liquid NDC 64743-283-01
- ECHINACEA PURPUREA 1 [hp_X]/mL Liquid NDC 64743-284-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Herbamed AG supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |